Search

Search Constraints

You searched for: Author/Creator Brandes, Alba A.

Search Results

1. A Commentary on Interstitial Pneumonitis Induced by Docetaxel: Clinical Cases and Systematic Review of the Literature. Issue 3 (May 2015)

2. A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma. Issue 8 (21st February 2016)

3. A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma. (28th September 2018)

4. AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma. Issue 9 (1st September 2016)

6. Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients. Issue 10 (October 2015)

7. Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients. Issue 10 (October 2015)

9. Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas. (September 2020)

10. Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study. (11th June 2019)